CenExel Clinical Research | Anaheim Clinical Trials

Research site

(Unclaimed)

Location

2441 W La Palma Avenue,  Suite 140, Anaheim, California, United States of America

Site insights

Top conditions

Top treatments

VX-548

PF-06882961

Risankizumab

Insulin icodec

PF-06700841

Maridebart Cafraglutide

LY3502970

PF-07081532

PF-06291874

AMG 133

Parent organization

This site is a part of CenExel Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

15 of 243 total trials

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

Researchers are looking for new weight loss medicines for people with higher body weight. The study medicine, MK-4082, is different from similar weig...

Active, not recruiting

Healthy

Drug: MK-4082

Drug: Placebo

A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-1403. The study will also measure what happe...

Enrolling

Diabetes Mellitus, Type 2

Drug: MK-1403 + additive coformulation

Drug: Placebo + additive coformulation

A Study of LY3867070 in Healthy Participants

The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will...

Enrolling

Healthy

Drug: LY3867070

Drug: Placebo

A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.

Active, not recruiting

Type 2 Diabetes Mellitus (T2DM)

Drug: Maridebart Cafraglutide

Drug: Placebo

A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants

The purpose of this study is to evaluate the pharmacokinetics (PK) of xanomeline following administration of KarXT in CYP2D6 normal/extensive, interm...

Enrolling

Healthy Volunteers

Drug: Xanomeline/ Trospium Chloride

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a...

Active, not recruiting

COVID-19

SARS-COV-2 Infection

Biological: Placebo

Biological: BNT162b2 Vaccine

A Study to Learn About a Vaccine Against E Coli in Healthy Adults

This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety...

Enrolling

Healthy Participants

Drug: E coli Vaccine 4 Dose C

Drug: E coli vaccine 3

A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

The purpose of the study is to learn how the study medicine called PF-07868489 is tolerated and acts in healthy adult people and people with pulmonar...

Active, not recruiting

Pulmonary Arterial Hypertension

Drug: Placebo for PF-07868489

Drug: PF-07868489

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia (ASCEND-QW)

This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the t...

Enrolling

Hypercholesterolemia

Drug: Alirocumab

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation (COURAGE)

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting

Obesity

Drug: Matching Placebo-Trevogrumab

Drug: Matching Placebo-Garetosmab

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.

The primary objective of this trial is to evaluate the pharmacokinetics (PK) of two evolocumab drug products in healthy participants.

Active, not recruiting

Healthy Participants

Drug: Evolocumab Drug Substance B (Reference)

Drug: Evolocumab Drug Substance A (Test)

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single and repeat doses of PF-07832837 in health...

Enrolling

Atopic Dermatitis

Healthy Participants

Other: Placebo

Drug: PF-07832837

Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).

Researchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. The...

Active, not recruiting

Healthy

Biological: V540B

Biological: GARDASIL®9 (G9)

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.

Enrolling

Cardiometabolic Disease

Drug: Placebo

Drug: AMG 513

To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults

An antibody is a substance your body makes to fight off infection. This study will explore the safety and antibody response of a vaccine to prevent s...

Active, not recruiting

Clostridoides Difficile Associated Disease

Biological: C. difficile vaccine formulation 1.

Biological: C. difficile vaccine formulation 2.